6 results
druginduced comparison differential erythematosus polychondritis relapsing summary systemic table tafro thrombocytopenia vasculitides vasculitis
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
Lupus (DIL): ... Constitutional symptoms ... SCLE-DIL (terbinafine ... #table #rheumatology ... #diagnosis #management
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
(SLE) - Diagnosis ... Manifestations: Malar rash ... versus DIL • ... life-threatening • Treatment ... #rheumatology
Drug Induced Lupus (DIL) • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
NPSLE rare, Malar rash ... SCLE-DIL (terbinafine ... #DIL #rheumatology ... #diagnosis #treatment ... #management
Vasculitis and Vasculitides - Differential Diagnosis Framework When to Consider Vasculitis: • Purpura, ischemic skin lesions •
tract, and often causes ... mucositis - Rash ... vasculitis, and SLE ... #rheumatology # ... classification
TAFRO TAFRO syndrome was first described in 2010, standing for: - Thrombocytopenia - Anasarca - Fever - Reticulin fibrosis - Organomegaly TAFRO syndrome
including systemic lupus ... erythematosus (SLE ... and the systemic symptoms ... Hypoalbuminemia Treatment ... #management #rheumatology
Relapsing Polychondritis What is it? Recurrent inflammation of the cartilage in the body (Autoimmune disorder) Who? • Most frequently: 40
• Inner ear • Skin ... such as: • SLE ... affected tissue Treatment ... Polychondritis #rheumatology ... #diagnosis #management
No results found for "IDSA diagnosis hematology pathophysiology algorithm rash lupus skin symptoms classification causes rheumatology complications sle dil management treatment"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #IDSA #diagnosis #hematology #pathophysiology #algorithm #rash #lupus #skin #symptoms #classification #causes #rheumatology #complications #sle #dil #management #treatment